Altogether, our findings highlight the dual role of LRP1 in the control of adipogenesis and lipid homeostasis, and suggest that LRP1 may be an important therapeutic target in obesity. Here, LRP1 is linked to obesity due to melanocortin 4 receptor deficiency.